Sunday 21st April 2024

Program

08:00 - 09:15

Breakfast and morning walk along the Pesaro seafront, optional

09:15 – 10:00

Plenary Session 2
Improving care and use of technology in children with type 1 diabetes: the role of clinical registrie 

Chair: Konstantinos Makrylakis

Antonio Nicolucci (Italy), Director CORESEARCH, Center for Outcomes Research and Clinical Epidemiology, Pescara

10:00 – 10:45

Poster Pitches & Boards, session 2
Epidemiology in diabetes

Chair: Alessandro Fontanarosa

Max. 2 min. poster pitches in the main hall, followed by ~30 minutes of questions/discussion next to poster boards in reception hall

PP&B10

MUNICIPAL AND DEPARTMENTAL PREDICTORS ASSOCIATED WITH THE PREVALENCE OF DIABETES MELLITUS IN COLOMBIA: A CROSS-SECTIONAL ANALYSIS

Juan Pablo Pérez Bedoya, Epidemiology Group, National Faculty of Public Health, University of Antioquia; Study Group on Type 1 Diabetes Epidemiology (EpiDiab), University of Antioquia, Medellín, Colombia

PP&B11

PREVALENCE AND TIME TRENDS OF DIABETES AMONG DANISH IVF PATIENTS

Gunnar Toft, Steno Diabetes Center Aarhus, Aarhus University Hospital, Denmark

PP&B12

INCIDENCE OF YOUTH ONSET DIABETES, BY TYPE, IN COLORADO FROM 2014-21

Tessa Crume, University of Colorado Anschutz Medical Center, Center for Lifecourse Epidemiology of Adiposity & Diabetes

PP&B13

BURDEN OF SELECTED NON-COMMUNICABLE CHRONIC DISEASES IN A PRIMARY HEALTHCARE SETTING IN NUUK, GREENLAND, AND A DANISH SUBURBAN POPULATION

Marie Balslev Backe, Steno Diabetes Center Greenland; Greenland Center for Health Research, Institute of Health and Nature, University of Greenland, Nuuk, Greenland; Steno Diabetes Center Copenhagen, Herlev, Denmark

PP&B14

FUTURE PREVALENCE OF TYPE 2 DIABETES IN GERMANY: AN UPDATED PROJECTION UNTIL 2040 INCLUDING INCIDENCE TRENDS OBSERVED DURING THE SARS-CoV-2 PANDEMIC

Thaddäus Tönnies, Institute for Biometrics and Epidemiology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University, Düsseldorf, Germany; Chair for Medical Biometry and Epidemiology (MBE), Witten/Herdecke University, Faculty of Health/School of Medicine, Witten, Germany

PP&B15

BLOOD GLUCOSE-LOWERING DRUG UTILIZATION IN ADULTS WITH DIABETES AT DIAGNOSIS IN MARCHE REGION, ITALY: A REAL-WORD POPULATION-BASED STUDY

Marica Iommi, Centre for Epidemiology, Biostatistics and Medical Informatics (EBI), Department of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona

PP&B16

PREVALENCE OF CHRONIC RENAL FAILURE IN PEOPLE LIVING WITH DIABETES IN FRANCE: ENTRED 3 STUDY

Céline Lavalette, Santé publique France, Saint Maurice, France

10:45 – 11:00

Exercise & tea/coffee break

11:00 – 12:00

Oral Presentation, session 3
Epidemiology in diabetes

Chair: Bendix Carstensen and Vera Bjarkø

10 min. presentations + 5 min. discussion

OP9

INCREASING INCIDENCE OF EARLY-ONSET TYPE 2 DIABETES IN SWEDEN 2007-2021

Sofia Carlsson, Institute of Environmental Medicine, Karolinska Institutet, Stockholm

OP10

INCREASED INCIDENCE OF TYPE 2 DIABETES OR THE EMERGING USE OF NOVEL GLUCOSE-LOWERING DRUGS IN INDIVIDUALS WITHOUT DIABETES?

Anders Aasted Isaksen, Steno Diabetes Center Aarhus, Aarhus, Denmark

OP11

FAMILIAL AGGREGATION AND HERITABILITY OF CHILDHOOD-ONSET AND ADULT-ONSET TYPE 1 DIABETES

Yuxia Wei, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

OP12

DEVELOPMENT AND INTERNAL VALIDATION OF INCIDENT TYPE 2 DIABETES RISK PREDICTION MODELS IN A SWEDISH COHORT

Melony Fortuin-de Smidt, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

12:00 – 13:00

Lunch

13:00 – 14:00

Oral Presentation, session 4
Diabetes & Lifestyle

Chair: Dorte Vistisen and Andrea Faragalli

10 min. presentations + 5 min. discussion

OP13

CONSOLIDATION EFFECTS OF A 6-MONTHS SUSTAINABLE LIFESTYLE INTERVENTION ON BIOMARKERS OF DIABETES AMONG ADULTS WITH OVERWEIGHT AND OBESITY IN OUAGADOUGOU, BURKINA FASO: A FAMILY-BASED, RANDOMIZED, CONTROLLED TRIAL

Ina Danquah, Heidelberg Institute of Global Health (HIGH), Medical Faculty and University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany; Hertz-Chair Innovation for Planetary Health, Center for Development Research (ZEF), University of Bonn, Bonn, Germany

OP14

THE LONGITUDINAL ASSOCIATION BETWEEN SOCIAL JETLAG AND GLYCEMIC AND METABOLIC CONTROL IN PEOPLE WITH PREDIABETES: AN IMI-DIRECT STUDY

Emma Bouman, Amsterdam UMC, location Vrije Universiteit, Epidemiology and Data Science

OP15

GLUCOSE LOWERING THROUGH WEIGHT MANAGEMENT (GLOW): A RANDOMISED

Simon Griffin, MRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, United Kingdom

OP16

PLANT-BASED DIETARY PATTERNS AND RISK OF ALL-CAUSE MORTALITY IN DIABETES SUBGROUPS: A PROSPECTIVE COHORT STUDY FROM THE UK BIOBANK

Edyta Szczerba, Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany; German Center for Diabetes Research (DZD), Partner Düsseldorf, Munich-Neuherberg, Germany

14:00 – 14:45

Plenary Session 3
The Potential of AI and Machine Learning in Precision Medicine and Healthcare: Addressing Methodological, Ethical, and Regulatory Challenges to Promote Good Research Practices

Chair: Adam Hulman

Paola Berchialla (Italy), Centre for Biostatistics, Epidemiology and Public Health (C-BEPH), University of Torino

Paolo Vineis
School of Public Health, Imperial College, Medical Research Council (MRC) Centre for Environment and Health, London, United Kingdom

15:00 – 19:30

Social outing

Cultural, Energising, Fun. We will keep this a surprise for now.

Paolo Vineis
School of Public Health, Imperial College, Medical Research Council (MRC) Centre for Environment and Health, London, United Kingdom

19:30 – 21:00

Dinner